Jennifer Barrett is senior editor for Drug Topics.
FDA approves topical for actinic keratosis
Tirbanibulin (Klisyri, Almirall) has been approved by the U.S. Food and Drug Administration (FDA) for the topical treatment of actinic keratosis on the face or scalp.
New Guidance Aims to Improve Genital Psoriasis Treatment
IL-23 and IL-17 Inhibitors Reduce Cardiovascular Outcomes in Statin-Treated Psoriasis Patients
Lurie Children’s Becomes First Treatment Center for Zevaskyn Gene Therapy in Patients with RDEB
Artax Biopharma's AX-158: A Novel Approach to T Cell-Driven Inflammation in Psoriasis